Lipidware Sdn Bhd is a Malaysian biotechnology startup from Universiti Putra Malaysia that develops clinically validated, science-backed skincare solutions, primarily under the REMDII brand, for eczema and sensitive skin management.
Lipidware Sdn Bhd is a Malaysian biotechnology company founded in 2017 as a university startup from Universiti Putra Malaysia (UPM) through the Putra Science Park InnoHub Programme. The company specializes in translating academic research into commercialized skincare solutions, most notably its REMDII brand. Developed by researchers in biotechnology and biochemistry, the company’s core innovation involves a patented bioactive delivery system that utilizes full-spectrum tocotrienols—a form of Vitamin E—to provide targeted anti-inflammatory and barrier-repair properties for sensitive and eczema-prone skin. This research-driven approach includes rigorous independent testing and ethics-approved human clinical trials to ensure safety and efficacy as a steroid-free alternative for individuals of all ages.
Beyond product development, Lipidware plays a significant role in community education and support through the Malaysia Eczema Support Community (MESC), which provides resources and guidance for patients and caregivers. The company’s efforts bridge the gap between clinical science and practical health management, addressing skin conditions such as atopic dermatitis, psoriasis, and actinic keratosis. Through its commitment to real science, Lipidware has earned numerous national and international accolades for innovation and commercialization, successfully moving university-backed breakthroughs from the laboratory to pharmacy shelves to improve patient quality of life.